| Denise Schultz |
dsc*****@bluebirdbio.com
|
bluebird bio |
Director, Regulatory Affairs CMC |
Biotechnology Research |
Sudbury, MA, US |
|
| Emily Swick |
esw***@bluebirdbio.com
|
bluebird bio |
Manager, Corporate Communications |
Biotechnology Research |
Boston, Massachusetts, United States |
|
| Frances Smith |
fsm***@bluebirdbio.com
|
bluebird bio |
Vice President |
Biotechnology Research |
Cambridge, MA, US |
|
| Karen Schorr |
ksc****@bluebirdbio.com
|
bluebird bio |
Chief Compliance Officer |
Biotechnology Research |
Cambridge, Massachusetts, United States |
|
| Eduardo Molina |
emo****@bluebirdbio.com
|
bluebird bio |
Vice President Marketing, Strategy and Analytics |
Biotechnology Research |
Boston, MA, US |
|
| Alison Conlon |
aco****@bluebirdbio.com
|
bluebird bio |
Vice President, Strategic Planning |
Biotechnology Research |
Cambridge, MA, US |
|
| Jill Ochoa |
joc***@bluebirdbio.com
|
bluebird bio |
Director, Quality Systems |
Biotechnology Research |
Cambridge, MA, US |
|
| Kate Haviland |
kha******@blueprintmedicines.com
|
Lengo Therapeutics |
Chief Executive Officer |
Biotechnology Research |
Boston, MA, US |
United States |
| Christina Rossi |
cro***@blueprintmedicines.com
|
Lengo Therapeutics |
Chief Operating Officer |
Biotechnology Research |
Somerville, MA, US |
United States |
| Fouad Namouni |
fna*****@blueprintmedicines.com
|
Lengo Therapeutics |
President, Research & Development |
Biotechnology Research |
Cambridge, MA, US |
United States |